Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.67 |
| ▸ | HTR2C | P28335 | 9/20 | 0.65 |
| ▸ | QDPR | P09417 | 2/20 | 0.54 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.50 |
| ▸ | NAMPT | P43490 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL30182435 | 0.87 | QDPR (0.53) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| Trifluoroacetic Acid SCHEMBL16799644 | 0.87 | HTR2C (0.71) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| SCHEMBL3899585 | 0.85 | SIGMAR1 (0.92) | SIGMAR1HTR2CQDPRNAMPTHTR6 | |
| Trifluoroacetic Acid SCHEMBL1198632 | 0.85 | SIGMAR1 (0.50) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| Trifluoroacetic Acid SCHEMBL29749858 | 0.84 | QDPR (0.50) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| Trifluoroacetic Acid SCHEMBL16228956 | 0.84 | SIGMAR1 (0.51) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| SCHEMBL415545 | 0.82 | SIGMAR1 (1.00) | SIGMAR1HTR2CQDPRHTR6HTR7 | |
| Trifluoroacetic Acid SCHEMBL30745981 | 0.81 | HTR2C (0.54) | SIGMAR1HTR2CQDPRP2RY14NAMPT | |
| Trifluoroacetic Acid SCHEMBL3322729 | 0.80 | HTR2C (0.50) | SIGMAR1HTR2CQDPRP2RY14HTR6 | |
| Bromide SCHEMBL11385943 | 0.80 | SIGMAR1 (0.96) | SIGMAR1HTR2CQDPRHTR6HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110088087-B | Tetrahydropyridine derivatives and their use as antibacterial agents | 东亚ST株式会社 | 2022-08-09 | — | — | CN | disclosed |
| EP-3519387-B1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG A ST CO LTD (KR) | 2021-08-11 | — | — | EP | disclosed |
| EP-3519387-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | Dong-A ST Co., Ltd. (KR) | 2019-08-07 | — | — | EP | disclosed |
| US-10160724-B2 | Tetrahydropyridine derivatives and their use as antibacterial agents | DONG-A ST CO., LTD. (KR) | 2018-12-25 | — | — | US | disclosed |
| WO-2018062924-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG-A ST CO., LTD. (KR) | 2018-04-05 | — | — | WO | disclosed |
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG-A ST CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | GALE, UGDH, PGLS | SIGMAR1 1438/4885HTR2C 1786/4885QDPR 42/4885 |
| US-10160724-B2 | Tetrahydropyridine derivatives and their use as antibacterial agents | GALE, UGDH, PGLS | SIGMAR1 1438/4885HTR2C 1786/4885QDPR 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.